| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 315,990 | 302,831 | 262,675 | 259,568 | | Cost of Revenue | 180,439 | 175,688 | 154,703 | 154,533 | | | Gross Profit | 135,551 | 127,143 | 107,972 | 105,035 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,753 | 36,143 | 32,515 | 29,950 | | Non Recurring | 139 | (1,683) | 507 | 60 | | Others | 34,897 | 33,265 | 27,316 | 25,752 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 64,762 | 59,418 | 47,634 | 49,273 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,012 | 288 | 1,030 | 2,779 | | Earnings Before Interest And Taxes | 65,684 | 59,706 | 48,664 | 50,804 | | Interest Expense | 12,260 | 12,308 | 12,249 | 11,843 | | Income Before Tax | 53,424 | 47,398 | 36,415 | 38,961 | | Income Tax Expense | 19,251 | 16,716 | 14,103 | 11,030 | | Minority Interest |
-
|
-
|
-
| (1,248) | | | | Net Income From Continuing Ops | 34,263 | 30,682 | 22,312 | 27,931 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,263 | 30,682 | 22,312 | 27,931 | | Preferred Stock And Other Adjustments | (113) | (244) | (334) |
-
| | | Net Income Applicable To Common Shares | $34,150 | $30,438 | $21,978 | $27,931 |
|
0.51% Nasdaq 
0.08 (0.24%) 
Income Statement
